Andromeda Surgical

The founders bring a blend of medical and technological expertise to the venture. Dr. Samer Abboud, who serves as CEO, has a background as a senior orthopedic surgeon specializing in knee and hip arthroplasty, and also holds an MBA. This combination of clinical experience and business acumen informs the company's strategic direction. Dr. Omri Lubovsky, the CTO, possesses a Ph.D. in Computer Science, specializing in surgical robotics from The Technion – Israel Institute of Technology, providing the deep technical knowledge necessary for product development.

Andromeda Surgical is developing an autonomous robotic system designed to assist in orthopedic surgeries. The core of their offering is a platform that utilizes advanced imaging, artificial intelligence, and autonomous robotics to perform specific surgical tasks. This system is intended to enhance precision and efficiency during operations. The business model appears to be centered on the development and subsequent sale or lease of this specialized surgical equipment to hospitals and surgical centers. The target clients are primarily orthopedic surgeons and healthcare institutions looking to adopt advanced surgical technologies.

The company's product aims to provide real-time, intra-operative data to surgeons, enabling more informed decision-making. By automating certain aspects of the surgical workflow, the system is designed to improve procedural accuracy and potentially reduce surgery times. A key feature is its focus on a compact, radiation-free system, which addresses common concerns regarding the large footprint and imaging requirements of existing robotic platforms. Andromeda Surgical has secured initial funding, including a pre-seed round and grants from the Israel Innovation Authority, which has supported its early-stage research and development efforts.